Conclusions: Lanthanum carbonate is effective and well tolerated, provided that recipients do not have preexisting liver disease. After 8 months of treatment, lanthanum was not detected in the mineralization front of bone. In hemodialysis patients, lanthanum carbonate does not seem to be involved in metabolic bone disease.
PMID: 22476966 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)